Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-12-07

FDA Approved: EBANGA — Supplemental Application (Emergent Manufacturing Operations Baltimore, LLC)

View source ↗

Summary

FDA approved a supplemental application to approve Emergent Manufacturing Operations Baltimore, LLC's facility for producing EBANGA (ansuvimab) used to treat Eb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ebanga (ansuvimab-zykl)

Snippet

SUPPL AP for EBANGA (ANSUVIMAB)